Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death.
Zhou C, Li W, Liang Z, Wu X, Cheng S, Peng J, Zeng K, Li W, Lan P, Yang X, Xiong L, Zeng Z, Zheng X, Huang L, Fan W, Liu Z, Xing Y, Kang L, Liu H.
Zhou C, et al. Among authors: lan p.
Nat Commun. 2024 Jan 12;15(1):499. doi: 10.1038/s41467-024-44779-1.
Nat Commun. 2024.
PMID: 38216551
Free PMC article.